what dose of semaglutide is considered microdosing One Size Does Not Fit All: Understanding for Diabetes in Multidose Pens what dose is considered microdosing
Description
BMI 30 or higher : Eligible based on weight alone
Regardless of whether your patients are using GLP-1 therapy, your standard of care remains
The SURPASS-4 trial showed that tirzepatide outperformed semaglutide for weight reduction in participants with obesity, making it an evidence-backed option
The only reason we seem to be upset as a society about the long term use of these medications is weight bias
Full receptor-coverage and evidence detail for each pick follows below
